Dexcom Highlights CGM Advances and Product Roadmap at ATTD 2026
During the conference, Dexcom showcased upcoming device updates, new platform features, and future innovations designed to expand and enhance its CGM ecosystem.
Glooko to Integrate Roche’s Accu-Chek SmartGuide CGM in Latest Partnership
The collaboration allows Accu-Chek's CGM data to flow into the Glooko platform, giving care teams a single dashboard to review glucose trends in select European markets.
Promising Results for Omnipod’s Type 2 Fully Closed-Loop Algorithm
Results from the EVOLUTION 2 trial presented at ATTD showed 68% time in range using a fully closed-loop system—with no mealtime boluses and minimal time below range.
The twiist Insulin Pump Officially Launches Nationwide in the U.S.
Sequel Med Tech's insulin pump moves beyond its limited release with new integrations and wider access for users and clinicians across the United States.
CamDiab Unveils Fully Closed-Loop Feature on CamAPS FX
The new Liberty feature allows people with type 1 diabetes to temporarily stop counting carbs or deliver boluses while CamAPS FX automatically manages glucose levels.
Senseonics Gets FDA Investigational Device Exemption for its Gemini Implantable CGM
The company behind the Eversense implantable CGM is one step closer to releasing a next-gen sensor that removes the requirement for an external transmitter.
FDA Issues Warning Letter Over Leaking Insulin Infusion Sets
A warning letter to Unomedical raises concerns about leaking infusion sets used with insulin pumps from Medtronic, Tandem Diabetes Care, and Beta Bionics.
Tandem is Shifting Toward a Pay-As-You-Go Model for its Insulin Pumps
The new model is meant to lower upfront costs and expand access, joining the broader industry move toward subscription-style pump access through pharmacies.
Afrezza Launches Trial to Bring Inhaled Insulin to Children With Type 1 Diabetes
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
Modular Medical Announces it's Insulin Pump Is Close to Commercial Launch
The company has began production of validation lots for its tubeless insulin pump aimed at “almost‐pumpers,” with plans for an early 2026 commercial debut still on track.
Dexcom Releases New “Trends” Tab on the Dexcom G7 App
Dexcom's G7 Trends tab offers users more diabetes insights, showcasing time in range, sensor usage, and key metrics, with more insights expected in the future.
The FDA Warns Abbott Over Libre CGM Accuracy Concerns
Following a 2025 recall of millions of sensors, the FDA points to gaps in Abbott’s quality verification process, sparking renewed discussion on device reliability.
